scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1007342318 |
P356 | DOI | 10.1186/CC7755 |
P932 | PMC publication ID | 2689479 |
P698 | PubMed publication ID | 19435472 |
P5875 | ResearchGate publication ID | 24420914 |
P50 | author | Rinaldo Bellomo | Q28321777 |
P2093 | author name string | Michael C Reade | |
Moritoki Egi | |||
P2860 | cites work | Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta | Q48436420 |
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. | Q51500191 | ||
Circadian rhythm of blood glucose values in critically ill patients. | Q53846806 | ||
Differentiation between septic and postburn insulin resistance. | Q54343641 | ||
Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units: Benefit Versus Harm | Q57245341 | ||
Glucose metabolism in man: responses to intravenous glucose infusion | Q67470780 | ||
Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability | Q71568252 | ||
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year | Q72351090 | ||
Glucose fluctuation on the progression of diabetic macroangiopathy--new findings from monocyte adhesion to endothelial cells | Q80225813 | ||
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 | Q24644984 | ||
Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
Intensive insulin therapy and pentastarch resuscitation in severe sepsis | Q28264234 | ||
The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
Intensive insulin therapy in critically ill patients | Q29618795 | ||
Benefits and risks of tight glucose control in critically ill adults: a meta-analysis | Q33363493 | ||
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock | Q34314380 | ||
Intensive insulin therapy in the medical ICU. | Q34490623 | ||
Glucose variability and mortality in patients with sepsis. | Q35222489 | ||
Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control | Q35651338 | ||
Perioperative diabetic and hyperglycemic management issues | Q35738424 | ||
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group | Q36244558 | ||
Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? | Q36744408 | ||
The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability | Q36993184 | ||
Glycemic variability: a strong independent predictor of mortality in critically ill patients | Q37282216 | ||
Variability of blood glucose concentration and short-term mortality in critically ill patients | Q40303337 | ||
Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture | Q43762927 | ||
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control | Q44308911 | ||
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation | Q44631833 | ||
Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes. | Q46275290 | ||
Blood glucose variability is associated with mortality in the surgical intensive care unit | Q46427807 | ||
Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity | Q46582052 | ||
Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR. | Q46846318 | ||
Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. | Q46906803 | ||
P433 | issue | 2 | |
P921 | main subject | glycobiology | Q899224 |
preproinsulin | Q7240673 | ||
P304 | page(s) | 302 | |
P577 | publication date | 2009-04-06 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy? | |
P478 | volume | 13 |
Q91768301 | Association of multiple glycemic parameters at intensive care unit admission with mortality and clinical outcomes in critically ill patients |
Q34807345 | Characteristics and effects of nurse dosing over-rides on computer-based intensive insulin therapy protocol performance |
Q37765323 | Clinical review: Strict or loose glycemic control in critically ill patients--implementing best available evidence from randomized controlled trials |
Q33821884 | Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin |
Q35952655 | Continuous Glucose Monitoring in Patients Undergoing Extracorporeal Ventricular Assist Therapy |
Q37867298 | Current and future treatment considerations in the management of aneurysmal subarachnoid hemorrhage |
Q37833518 | Glucose variability measures and their effect on mortality: a systematic review |
Q98771370 | Glycemic Variability: An Independent Predictor of Mortality and the Impact of Age in Pediatric Intensive Care Unit |
Q37640683 | Glycemic control in critically ill patients. |
Q46275849 | Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients |
Q37789585 | Intensive insulin therapy during cardiovascular surgery |
Q24282606 | Limitations of medical research and evidence at the patient-clinician encounter scale |
Q37867296 | Management of spontaneous nontraumatic intracranial hemorrhage |
Q39974347 | NICE-SUGAR: the end of a sweet dream? |
Q34153353 | The use of exenatide in severely burned pediatric patients |
Search more.